(Q43829325)

27 November 2017

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans (English)

1 reference

27 November 2017

0 references

Phillip R Pittman

1

1 reference

27 November 2017

Gina Kim-Ahn

2

1 reference

27 November 2017

Dominique Y Pifat

3

1 reference

27 November 2017

Kevin Coonan

4

1 reference

27 November 2017

Paul Gibbs

5

1 reference

27 November 2017

Steve Little

6

1 reference

27 November 2017

Judith G Pace-Templeton

7

1 reference

27 November 2017

Robert Myers

8

1 reference

27 November 2017

Gerald W Parker

9

1 reference

27 November 2017

Arthur M Friedlander

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

27 November 2017

20

1 reference

27 November 2017

1412-1420

1 reference

27 November 2017

9-10

1 reference

Iraq's biological weapons. The past as future?

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

1 reference

7 January 2021

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

A case of anthrax sepsis: non-fatal course

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Anthrax vaccine: short-term safety experience in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

In vitro correlate of immunity in an animal model of inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900462-5

7 January 2021

10.1016/S0264-410X(01)00462-5

Identifiers

DOI

1 reference

27 November 2017

1 reference